Fengfei Ma

Fengfei Ma

Auto-generated profile, based on publicly available information

Fengfei Ma

University of Wisconsin-Madison

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZihui Li
Zihui Li
DTDaniel M. Tremmel
Daniel M. Tremmel
FMFengfei Ma
Fengfei Ma
QYQinying Yu
Qinying Yu
MMMin Ma
Min Ma
LLLingjun Li
Lingjun Li
The extracellular matrix (ECM) is unique to each tissue and capable of guiding cell differentiation, migration, morphology, and function. The ECM proteome of different developmental stages has not been systematically studied in the human pancreas. In this study, we apply mass spectrometry-based quantitative proteomics strategies using N,N-dimethyl leucine isobaric tags to delineate proteome-wide and ECM-specific alterations in four age groups: fetal (18-20 weeks gestation), juvenile (5-16 years old), young adults (21-29 years old) and older adults (50-61 years old). We identify 3,523 proteins including 185 ECM proteins and quantify 117 of them. We detect previously unknown proteome and matrisome features during pancreas development and maturation. We also visualize specific ECM proteins of interest using immunofluorescent staining and investigate changes in ECM localization within islet or acinar compartments. This comprehensive proteomics analysis contributes to an improved understanding of the critical roles that ECM plays throughout human pancreas development and maturation.

1 January 2020 in mAbs
Verified
Journal Article
Open access
FMFengfei Ma
Fengfei Ma
FRFahimeh Raoufi
Fahimeh Raoufi
MBMarc Andre Bailly
Marc Andre Bailly
LFLaurence Fayadat-Dilman
Laurence Fayadat-Dilman
DTDaniela Tomazela
Daniela Tomazela
Characterization of charge heterogeneity in monoclonal antibodies (mAbs) is needed during developability assessment and downstream development of drug candidates. Charge heterogeneity can come from post-translational modifications like deamidation, isomerization, and sialylation. Elucidation of charge variants with mass spectrometry (MS) has historically been challenging. Due to the nonvolatility and high ionic strength of conventional buffer systems, labor-intensive offline fractionation followed by MS analysis is routinely used. Here, we describe an alternative strategy that directly couples strong cation exchange (SCX) chromatography to high-resolution Orbitrap MS for online native MS analysis (SCX-MS). A combined pH and salt gradient was used for universal separation of mAbs from a wide range of pI values (6.38 ~ 9.2), including infliximab (Remicade®, chimeric IgG1/kappa), NISTmab (humanized IgG1/kappa) and trastuzumab (Herceptin®, humanized IgG1/kappa), without tailoring of chromatographic profiles. Liquid chromatography and MS parameters were optimized to achieve high-quality spectra and enhanced detection of low abundant species under high flow rate conditions. Genedata Expressionist, a vendor agnostic software, was used for data processing. This integrated strategy allows unbiased characterization of numerous charge variant species and low molecular weight fragments (<0.05%) without post-column flow splitting. The application was further expanded with middle-up approaches for subdomain analysis, which demonstrated the versatility of the strategy for analysis of various construct types. With our analysis of mAbs during developability assessment and forced degradation studies, which aimed at assessing potential critical quality attributes in antibody drug molecules, we provide, for the first time, direct visualization of molecular alterations of mAbs at intact level. Furthermore, strong correlation was observed between this novel MS approach and analysis by capillary isoelectric focusing.

13 May 2024 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
TZTingting Zhang
Tingting Zhang
DADaosheng Ai
Daosheng Ai
PWPingli Wei
Pingli Wei
YXYing Xu
Ying Xu
ZBZhanying Bi
Zhanying Bi
WGWoo-Ping Ge
Woo-Ping Ge

31 March 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
FMFengfei Ma
Fengfei Ma
ASA. Carl Sanchez
A. Carl Sanchez
JSJames Song
James Song
EKEsther Kofman
Esther Kofman
DTDaniela Tomazela
Daniela Tomazela
MAMohammad Ahmed Al-Sayah
Mohammad Ahmed Al-Sayah

1 June 2019 in URINE
Verified
Journal Article
Open access
PWPingli Wei
Pingli Wei
LHLing Hao
Ling Hao
FMFengfei Ma
Fengfei Ma
QYQing Yu
Qing Yu
ABAmanda Rae Buchberger
Amanda Rae Buchberger
LLLingjun Li
Lingjun Li
Lower urinary tract symptoms (LUTS) are common among aging men. Since prostatic inflammation is one of its etiologies, it is plausible that urinary metabolite and protein biomarkers could be identified and used to diagnose inflammation-induced LUTS. We characterized the urine metabolome and proteome in a mouse model of bacterial-induced prostatic inflammation. Mass Spectrometry (MS)-based multi-omics analysis was employed to discover urinary protein and metabolite-based biomarkers. The investigation of isobaric dimethylated leucine (DiLeu) labeling on metabolites allowed metabolomics and proteomics analysis on the same liquid chromatography (LC)-MS platform. In total, 143 amine-containing metabolites and 1058 urinary proteins were identified and quantified (data are available via ProteomeXchange with identifier PXD018023); among them, 14 metabolites and 168 proteins were significantly changed by prostatic inflammation. Five metabolic pathways and four inflammation-related biological processes were potentially disrupted. By comparing our findings with urinary biomarkers identified in a mouse model of genetic-induced prostate inflammation and with those previously found to be associated with LUTS in older men, we identified creatine, haptoglobin, immunoglobulin kappa constant and polymeric Ig receptor as conserved biomarkers for prostatic inflammation associated with LUTS. These data suggest that these putative biomarkers could be used to identify men in which prostate inflammation is present and contributing to LUTS.

26 September 2024 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
EJEunju Jang
Eunju Jang
FMFengfei Ma
Fengfei Ma
DTDaniela Tomazela
Daniela Tomazela
LFLaurence Fayadat-Dilman
Laurence Fayadat-Dilman
MAMohammad Ahmed Al-Sayah
Mohammad Ahmed Al-Sayah